Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Xilio Therapeutics, Inc. (XLO)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
8 Feb 2024
Atlas Venture Fund XI, L.P.
10% Owner
Xilio Therapeutics, Inc.
(XLO)
2,019,563
-0%
1,000
$0.64
$640.00
SELL
11 Jan 2024
Atlas Venture Fund XI, L.P.
10% Owner
Xilio Therapeutics, Inc.
(XLO)
2,020,296
-0%
4,235
$0.85
$3,600.45
BUY
8 Dec 2021
Bain Capital Life Sciences Investors, LLC
10% Owner
Xilio Therapeutics, Inc.
(XLO)
2,802,225
+1%
42,469
$9.66
$410,161.40
BUY
26 Oct 2021
Atlas Venture Fund XI, L.P.
10% Owner
Xilio Therapeutics, Inc.
(XLO)
735,942
+34%
187,500
$16.00
$3,000,000.00
BUY
26 Oct 2021
Rock Springs Capital Management LP
10% Owner
Xilio Therapeutics, Inc.
(XLO)
1,256,472
+66%
500,000
$16.00
$8,000,000.00
BUY
26 Oct 2021
Flynn James E
10% Owner, Possible Member of 10% Group
Xilio Therapeutics, Inc.
(XLO)
1,143,972
+210%
775,000
$16.00
$12,400,000.00
BUY
26 Oct 2021
BAY CITY CAPITAL LLC
10% Owner
Xilio Therapeutics, Inc.
(XLO)
1,129,490
+38%
312,500
$16.00
$5,000,000.00
BUY
26 Oct 2021
RiverVest Venture Fund IV, L.P.
10% Owner
Xilio Therapeutics, Inc.
(XLO)
1,441,444
+20%
250,000
$16.00
$4,000,000.00
Home